Personal profile
Academic discipline
MEDS-09/B - Blood Diseases
Fingerprint
Dive into the research topics where Luca Laurenti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country level (based on research outputs with Scopus ID). Dive into details by clicking on the dots.
-
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience
Innocenti, I., Tomasso, A., Giannarelli, D., Scarfò, L., Murru, R., Visentin, A., Frustaci, A. M., Morelli, F., Vitale, C., Mosca, A., Sanna, A., Farina, G., Laureana, R., Gentile, M., Galitzia, A., Pasquale, R., Autore, F., Olivieri, J., Romeo, A. & Deodato, M. & 12 others, , 2025, In: Hematological Oncology. 43, 1, p. N/A-N/AResearch output: Contribution to journal › Article
-
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
Autore, F., Visentin, A., Deodato, M., Vitale, C., Galli, E., Fresa, A., Fazzi, R., Sanna, A., Olivieri, J., Scortechini, I., Del Principe, M. I., Sportoletti, P., Innocenti, I., Coscia, M., Tedeschi, A., Trentin, L., Candoni, A., Busca, A., Pagano, L. & Laurenti, L., 2025, In: Blood advances. 9, 1, p. 162-165 4 p.Research output: Contribution to journal › Article
-
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study
Fresa, A., Innocenti, I., Tomasso, A., Vitale, C., Sanna, A., Frustaci, A. M., Visentin, A., Romeo, A., Sportoletti, P., Giordano, A., Perutelli, F., Murru, R., Mauro, F. R., Mosca, A., Morelli, F., Laureana, R., Galitzia, A., Angeletti, I., Conte, E. & Moia, R. & 16 others, , 2025, In: Blood advances. 9, 21, p. 5399-5408 10 p.Research output: Contribution to journal › Article
-
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies
Autore, F., Tedeschi, A., Benevolo, G., Mattiello, V., Galli, E., Danesin, N., Rizzi, R., Olivieri, J., Cencini, E., Puccini, B., Ferrarini, I., Marino, D., Bullo, M., Rossini, B., Motta, M., Innocenti, I., Fresa, A., Stirparo, L., Petrilli, D. & Pasquale, R. & 10 others, , 2025, In: American Journal of Hematology. 100, 1, p. 189-191 3 p.Research output: Contribution to journal › Article
-
Ibrutinib increases miR-181a/b in leukemic cells from patients with chronic lymphocytic leukemia
Ramassone, A., Pagotto, S., Di Marco, M., Rashid, M. M., Di Camillo, C., Palmiero, F., Innocenti, I., Autore, F., Tomasso, A., Laurenti, L. & Visone, R., 2025, In: Blood advances. 9, 19, p. 4891-4895 5 p.Research output: Contribution to journal › Article